The stock market fell sharply anew on Wednesday, with all major indices ending in the red, as investor sentiment was dampened ...

We recently published a list of Biotech Stocks Dominate Monday’s Top 10 Gainers. In this article, we are going to take a look ...

CULVER CITY, Calif., April 15, 2025--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that it has completed multiple submissions to the FDA including an sBLA for ...

ImmunityBio, Inc.’s IBRX share price has dipped by 6.65%, which has investors questioning if this is right time to buy.

US biotech ImmunityBio (Nasdaq: IBRX) has secured $75 million through a direct offering with a single institutional investor, ...

ImmunityBio (IBRX) announced that it has executed financing to provide further working capital and support its ongoing business operations. The ...

ImmunityBio Trading Down 1.0 % Shares of IBRX stock opened at $2.87 on Friday. ImmunityBio has a twelve month low of $2.28 and a twelve month high of $10.53. The stock has a market capitalization ...

In this article, we are going to take a look at where ImmunityBio Inc. (NASDAQ:IBRX) stands against other stocks that outperformed broader market last week. Wall Street’s main indices traded ...

The latest analyst rating for ImmunityBio (NASDAQ:IBRX) was provided by HC Wainwright & Co., and ImmunityBio reiterated their buy rating. The last downgrade for ImmunityBio Inc happened on May 12 ...

Teacher Retirement System of Texas grew its stake in shares of ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) by 20.4% in the 4th quarter, according to its most recent Form 13F filing with the ...